(GIM) GI Multiple Sites Clinical Trials

1. (CGIM08030) (S0518): Phase III Prospective Randomized Comparison of Depot Octreotide plus Interferon Alpha versus Depot Octreotide plus Bevacizumab (NSC #704865) in Advanced, Poor Prognosis Carcinoid Patients